|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Claassens L, van Meerbeeck J, Coens C,
Quinten C, Ghislain I, Sloan EK, Wang XS, Velikova G and Bottomley
A: Health-related quality of life in non-small-cell lung cancer: An
update of a systematic review on methodologic issues in randomized
controlled trials. J Clin Oncol. 29:2104–2120. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu
Y, Chen Y, Xu L, Zen K, Zhang C, et al: Serum microRNA signatures
identified in a genome-wide serum microRNA expression profiling
predict survival of non-small-cell lung cancer. J Clin Oncol.
28:1721–1726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Y, Ma C, Qian M, Wen Z, Jing H and Qian
D: Downregulation of NOB1 suppresses the proliferation and tumor
growth of non-small cell lung cancer in vitro and in
vivo. Oncol Rep. 31:1271–1276. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mahdian-Shakib A, Dorostkar R, Tat M,
Hashemzadeh MS and Saidi N: Differential role of microRNAs in
prognosis, diagnosis, and therapy of ovarian cancer. Biomed
Pharmacother. 84:592–600. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nassar FJ, Nasr R and Talhouk R: MicroRNAs
as biomarkers for early breast cancer diagnosis, prognosis and
therapy prediction. Pharmacol Ther. 172:34–49. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim VN: MicroRNA biogenesis: Coordinated
cropping and dicing. Nat Rev Mol Cell Biol. 6:376–385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li S, Gao M, Li Z, Song L, Gao X, Han J,
Wang F, Chen Y, Li W, Yang J, et al: Role of microRNAs in
metastasis of non-small cell lung cancer. Front Biosci (Landmark
Ed). 21:998–1005. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng B, Zhang K, Wang R and Chen L:
Non-small-cell lung cancer and miRNAs: Novel biomarkers and
promising tools for treatment. Clin Sci (Lond). 128:619–634. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang H, Li P and Zhao B: Knockdown of NOB1
expression by RNAi inhibits cellular proliferation and migration in
human gliomas. Gene. 528:146–153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin Y, Peng S, Yu H, Teng H and Cui M:
RNAi-mediated downregulation of NOB1 suppresses the growth and
colony-formation ability of human ovarian cancer cells. Med Oncol.
29:311–317. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Y, Ni J, Zhou G, Yuan J, Ren W, Shan
Y, Tang W, Yu L and Zhao S: Cloning, expression and
characterization of the human NOB1 gene. Mol Biol Rep. 32:185–189.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Veith T, Martin R, Wurm JP, Weis BL,
Duchardt-Ferner E, Safferthal C, Hennig R, Mirus O, Bohnsack MT,
Wöhnert J, et al: Structural and functional analysis of the
archaeal endonuclease Nob1. Nucleic Acids Res. 40:3259–3274. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu Z, Guo Q, Shi A, Xie F and Lu Q:
Downregulation of NIN/RPN12 binding protein inhibit the growth of
human hepatocellular carcinoma cells. Mol Biol Rep. 39:501–507.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin S, Meng W, Zhang W, Liu J, Wang P, Xue
S and Chen G: Expression of the NOB1 gene and its clinical
significance in papillary thyroid carcinoma. J Int Med Res.
41:568–572. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang X, Zhang D, Qu F, Hong Y, Cao J, Pan
X, Li L, Huang Y, Huang H, Yin L, et al: Knockdown of NOB1
expression inhibits the malignant transformation of human prostate
cancer cells. Mol Cell Biochem. 396:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen B, Liu J, Wu D, Qin Y, Peng C, Li C
and Wang J: Gene silencing of NOB1 by lentivirus suppresses growth
and migration of human osteosarcoma cells. Mol Med Rep.
9:2173–2179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu K, Chen HL, Gu MM and You QS:
Relationship between NOB1 expression and prognosis of resected
non-small cell lung cancer. Int J Biol Markers. 30:e43–e48. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu K, Gu MM, Chen HL and You QS: NOB1 in
non-small-cell lung cancer: Expression profile and clinical
significance. Pathol Oncol Res. 20:461–466. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang W, Zhong W, Xu J, Su B, Huang G, Du
J and Liu Q: Lentivirus-mediated gene silencing of NOB1 suppresses
non-small cell lung cancer cell proliferation. Oncol Rep.
34:1510–1516. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yiwei T, Hua H, Hui G, Mao M and Xiang L:
HOTAIR interacting with MAPK1 regulates ovarian cancer SKOV3 cell
proliferation, migration, and invasion. Med Sci Monit.
21:1856–1863. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tréhoux S, Lahdaoui F, Delpu Y, Renaud F,
Leteurtre E, Torrisani J, Jonckheere N and Van Seuningen I:
Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by
targeting the MUC1 mucin in pancreatic cancer cells. Biochim
Biophys Acta. 1853:2392–2403. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu H, Xu Z, Li C, Xu C, Lei Z, Zhang HT
and Zhao J: MiR-145 and miR-203 represses TGF-β-induced
epithelial-mesenchymal transition and invasion by inhibiting SMAD3
in non-small cell lung cancer cells. Lung Cancer. 97:87–94. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun CC, Li SJ and Li DJ: Hsa-miR-134
suppresses non-small cell lung cancer (NSCLC) development through
down-regulation of CCND1. Oncotarget. 7:35960–35978. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen W, Wang J, Liu S, Wang S, Cheng Y,
Zhou W, Duan C and Zhang C: MicroRNA-361-3p suppresses tumor cell
proliferation and metastasis by directly targeting SH2B1 in NSCLC.
J Exp Clin Cancer Res. 35:762016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Maffioletti E, Cattaneo A, Rosso G, Maina
G, Maj C, Gennarelli M, Tardito D and Bocchio-Chiavetto L:
Peripheral whole blood microRNA alterations in major depression and
bipolar disorder. J Affect Disord. 200:250–258. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cohen JE, Lee PR and Fields RD: Systematic
identification of 3′-UTR regulatory elements in activity-dependent
mRNA stability in hippocampal neurons. Philos Trans R Soc Lond B
Biol Sci. 369:3692014. View Article : Google Scholar
|
|
30
|
Yoo JK, Kim CH, Jung HY, Lee DR and Kim
JK: Discovery and characterization of miRNA during cellular
senescence in bone marrow-derived human mesenchymal stem cells. Exp
Gerontol. 58:139–145. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rambow F, Bechadergue A, Saintigny G,
Morizot F, Mahé C and Larue L: miR-330-5p targets tyrosinase and
induces depigmentation. J Invest Dermatol. 134:2846–2849. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim BK, Yoo HI, Choi K and Yoon SK:
miR-330-5p inhibits proliferation and migration of keratinocytes by
targeting Pdia3 expression. FEBS J. 282:4692–4702. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim BK, Yoo HI, Choi K, Lee AR and Yoon
SK: Regulation of Srpr expression by miR-330-5p controls
proliferation of mouse epidermal keratinocyte. PLoS One.
11:e01648962016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Su BB, Zhou SW, Gan CB and Zhang XN:
MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses
cell proliferation and invasion in cutaneous malignant melanoma. J
Surg Res. 203:434–440. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fooladinezhad H, Khanahmad H,
Ganjalikhani-Hakemi M and Doosti A: Negative regulation of TIM-3
expression in AML cell line (HL-60) using miR-330-5p. Br J Biomed
Sci. 73:129–133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yoo HI, Kim BK and Yoon SK:
MicroRNA-330-5p negatively regulates ITGA5 expression in human
colorectal cancer. Oncol Rep. 36:3023–3029. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bibby BA, Reynolds JV and Maher SG:
MicroRNA-330-5p as a putative modulator of neoadjuvant
chemoradiotherapy sensitivity in oesophageal adenocarcinoma. PLoS
One. 10:e01341802015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Che JP, Li W, Yan Y, Liu M, Wang GC, Li
QY, Yang B, Yao XD and Zheng JH: Expression and clinical
significance of the nin one binding protein and p38 MAPK in
prostate carcinoma. Int J Clin Exp Pathol. 6:2300–2311.
2013.PubMed/NCBI
|
|
39
|
Liu Y, Huang H, Yuan B, Zhuang LY, Luo TP
and Zhang Q: Lentivirus-mediated knockdown of NOB1 suppresses the
proliferation of colon cancer cells. Z Gastroenterol. 52:429–435.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gao X, Wang J, Bai W, Ji W and Wang L:
NOB1 silencing inhibits the growth and metastasis of laryngeal
cancer cells through the regulation of JNK signaling pathway. Oncol
Rep. 35:3313–3320. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu J, Dong BF, Wang PS, Ren PY, Xue S,
Zhang XΝ, Han Z and Chen G: Silencing NOB1 enhances doxorubicin
antitumor activity of the papillary thyroid carcinoma in
vitro and in vivo. Oncol Rep. 33:1551–1559.
2015.PubMed/NCBI
|
|
42
|
Meng W, Wang PS, Liu J, Xue S, Wang GM,
Meng XY and Chen G: Adenovirus-mediated siRNA targeting NOB1
inhibits tumor growth and enhances radiosensitivity of human
papillary thyroid carcinoma in vitro and in vivo.
Oncol Rep. 32:2411–2420. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu K, Chen HL, Gu MM and You QS: NOB1
expression predicts early response to cisplatin-based chemotherapy
in patients with advanced non-small cell lung cancer. J Chemother.
28:225–229. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu K, Chen HL, Wang S, Gu MM, Chen XM,
Zhang SL, Yu KJ and You QS: High Expression of RIOK2 and NOB1
Predict Human Non-small Cell Lung Cancer Outcomes. Sci Rep.
6:286662016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhou J, Xu T, Yan Y, Qin R, Wang H, Zhang
X, Huang Y, Wang Y, Lu Y, Fu D, et al: MicroRNA-326 functions as a
tumor suppressor in glioma by targeting the Nin one binding protein
(NOB1). PLoS One. 8:e684692013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu L, Hui H, Wang LJ, Wang H, Liu QF and
Han SX: MicroRNA-326 functions as a tumor suppressor in colorectal
cancer by targeting the nin one binding protein. Oncol Rep.
33:2309–2318. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ji S, Zhang B, Kong Y, Ma F and Hua Y:
MiR-326 inhibits gastric cancer cell growth through down regulating
NOB1. Oncol Res. 25:853–861. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li W, Liu M, Feng Y, Xu YF, Huang YF, Che
JP, Wang GC, Yao XD and Zheng JH: Downregulated miR-646 in clear
cell renal carcinoma correlated with tumour metastasis by targeting
the nin one binding protein (NOB1). Br J Cancer. 111:1188–1200.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sun J, Fan Z, Lu S, Yang J, Hao T and Huo
Q: MiR-192 suppresses the tumorigenicity of prostate cancer cells
by targeting and inhibiting nin one binding protein. Int J Mol Med.
37:485–492. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Huang P, Xi J and Liu S: MiR-139-3p
induces cell apoptosis and inhibits metastasis of cervical cancer
by targeting NOB1. Biomed Pharmacother. 83:850–856. 2016.
View Article : Google Scholar : PubMed/NCBI
|
